Skip to main content

Alcohol Drinking

1
Pipeline Programs
6
Companies
7
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
1
NaltrexonePhase 1/21 trial
Healthy Families Bright Futures ProgramN/A1 trial
Active Trials
NCT06309134Recruiting160Est. Aug 2026
NCT04854551Completed13Est. Apr 2022
Martin Pharmaceuticals
1 program
AlcoholN/A1 trial
Active Trials
NCT03521817Completed12Est. Nov 2019
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
GlutathioneN/A1 trial
Active Trials
NCT00127309Completed100Est. Aug 2005
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Intervention condition, the usual prenatal care plus the alcohol interventionN/A1 trial
Active Trials
NCT05766761Recruiting600Est. Apr 2027
Innovation Pharmaceuticals
1 program
Media DetectiveN/A1 trial
Active Trials
NCT01060852Completed679Est. Jun 2007
Labcorp
LabcorpBURLINGTON, NC
1 program
blood microsamplingN/A1 trial
Active Trials
NCT06084832Recruiting628Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Colorado TherapeuticsNaltrexone
Colorado TherapeuticsHealthy Families Bright Futures Program
Purdue PharmaIntervention condition, the usual prenatal care plus the alcohol intervention
Labcorpblood microsampling
Martin PharmaceuticalsAlcohol
Innovation PharmaceuticalsMedia Detective
UNION therapeuticsGlutathione

Clinical Trials (7)

Total enrollment: 2,192 patients across 7 trials

NCT04854551Colorado TherapeuticsNaltrexone

Opioid Modulation and Neural Reward Activation in Healthy Adults

Start: May 2021Est. completion: Apr 202213 patients
Phase 1/2Completed
NCT06309134Colorado TherapeuticsHealthy Families Bright Futures Program

The Healthy Families Bright Futures Program

Start: Jan 2025Est. completion: Aug 2026160 patients
N/ARecruiting
NCT05766761Purdue PharmaIntervention condition, the usual prenatal care plus the alcohol intervention

Reducing Alcohol Exposed Pregnancies

Start: Apr 2024Est. completion: Apr 2027600 patients
N/ARecruiting
NCT06084832Labcorpblood microsampling

Smartphone Application for University Students With Binge Drinking Behavior

Start: Oct 2023Est. completion: Jul 2026628 patients
N/ARecruiting
NCT03521817Martin PharmaceuticalsAlcohol

The Effects of Alcohol Consumption on Central Adiposity

Start: May 2018Est. completion: Nov 201912 patients
N/ACompleted
NCT01060852Innovation PharmaceuticalsMedia Detective

Evaluation of the Media Detective Program for Elementary School-Aged Children to Prevention Substance Use

Start: Mar 2006Est. completion: Jun 2007679 patients
N/ACompleted
NCT00127309UNION therapeuticsGlutathione

Effect of Glutathione on Blood Alcohol and Hangover Symptoms

Start: Jun 2005Est. completion: Aug 2005100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 2,192 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.